Top Markets
#1 Gravity Gravity +75.10%
#2 Galxe Galxe +57.82%
#3 TENDIES TENDIES +36.20%
#4 Railgun Railgun +36.15%
#5 Geodnet Geodnet +24.60%
#6 Fake World Assets Fake World Assets +23.71%
#7 Akedo Akedo +22.61%
#8 Injective Injective +16.93%
#9 Kinetiq Kinetiq +16.68%
#10 Collector Crypt Collector Crypt +16.50%
Coin of the day
Gravity Gravity
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classifica tra le azioni #36
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Prezzo delle azioni
$484.33
Capitalizzazione di mercato
$379.69B
Variazione (1 giorno)
1.03%
Variazione (1 anno)
46.81%
Paese
CH
Scambia Roche Holding AG (RO)

Categoria

Healthcare
Rapporto P/B per Roche Holding AG (RO)
Rapporto P/B al September 2026 TTM: 7.59
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Roche Holding AG, il rapporto P/B attuale (TTM) è 7.59. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Roche Holding AG da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 29.9692 294.86%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6479 0.77%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -78.0908 -1,128.89%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.5385 12.50%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 6.754 -11.01%
CH